Short Interest in Research Solutions Inc. (NASDAQ:RSSS) Grows By 218.3%

Research Solutions Inc. (NASDAQ:RSSS) was the recipient of a large growth in short interest in the month of September. As of September 30th, there was short interest totaling 57,300 shares, a growth of 218.3% from the September 15th total of 18,000 shares. Based on an average daily trading volume, of 108,500 shares, the days-to-cover ratio is presently 0.5 days. Based on an average daily trading volume, of 108,500 shares, the days-to-cover ratio is presently 0.5 days.

Research Solutions Trading Down 3.4%

Research Solutions stock opened at $3.14 on Friday. Research Solutions has a 12-month low of $2.32 and a 12-month high of $4.24. The stock has a market cap of $103.05 million, a P/E ratio of 104.70, a price-to-earnings-growth ratio of 3.61 and a beta of 0.66. The company has a fifty day simple moving average of $3.32 and a 200-day simple moving average of $2.95.

Research Solutions (NASDAQ:RSSS) last posted its earnings results on Thursday, September 18th. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.04. The firm had revenue of $12.44 million during the quarter, compared to analysts’ expectations of $12.51 million. Research Solutions had a return on equity of 10.32% and a net margin of 2.58%.During the same quarter in the previous year, the business earned ($0.08) earnings per share. As a group, sell-side analysts forecast that Research Solutions will post 0.05 earnings per share for the current fiscal year.

Institutional Trading of Research Solutions

A number of hedge funds and other institutional investors have recently made changes to their positions in RSSS. Evernest Financial Advisors LLC acquired a new stake in shares of Research Solutions in the 2nd quarter valued at about $35,000. NewEdge Advisors LLC purchased a new position in shares of Research Solutions during the 1st quarter worth approximately $71,000. Topline Capital Management LLC acquired a new stake in Research Solutions in the second quarter valued at $125,000. Acadian Asset Management LLC boosted its holdings in Research Solutions by 83.7% during the first quarter. Acadian Asset Management LLC now owns 87,327 shares of the company’s stock worth $225,000 after buying an additional 39,789 shares in the last quarter. Finally, Punch & Associates Investment Management Inc. boosted its stake in shares of Research Solutions by 1.6% during the 1st quarter. Punch & Associates Investment Management Inc. now owns 2,367,771 shares of the company’s stock worth $6,156,000 after acquiring an additional 37,651 shares in the last quarter. Institutional investors and hedge funds own 33.60% of the company’s stock.

Analysts Set New Price Targets

RSSS has been the topic of a number of recent research reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Research Solutions in a research note on Wednesday, October 8th. Wall Street Zen upgraded shares of Research Solutions to a “strong-buy” rating in a report on Saturday, October 11th. Finally, Roth Capital raised their price target on shares of Research Solutions from $4.35 to $5.00 and gave the company a “buy” rating in a research report on Friday, September 19th. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $5.00.

About Research Solutions

Research Solutions, Inc, through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover platform that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including free basic search solutions and advanced search tools, which include the Resolute.ai and scite.ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer’s internal datasets.